Data on elderly patients with RCC.

This retrospective study enrolled consecutive patients aged 75 years or over with histologically confirmed renal cell carcinoma (RCC) who were treated at Peking University Third Hospital between January 2012 and December 2024. All participants underwent partial or radical nephrectomy, performed by urological oncology specialists. Adjuvant therapy was administered according to contemporary clinical guidelines. Comprehensive clinical data were systematically collected, including demographic parameters (gender, age at diagnosis and BMI), chief symptoms, American Society of Anesthesiologists (ASA) physical status classification and Charlson Comorbidity Index (CCI) scores for mortality risk stratification The primary endpoint of the study was all-cause mortality, with follow-up conducted until the end of December 2024.